The arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients, according to a French clinical study. The treatment, which suppresses the body’s natural…
Read More Arthritis drug shows ‘significant’ promise in severe COVID-19 cases – Study